Archives for: August 31st, 2020

CORMEDIX INC. ANNOUNCES FDA ACCEPTANCE FOR FILING AND PRIORITY REVIEW OF NEW DRUG APPLICATION FOR DEFENCATH

Written by Sam Nelson on August 31, 2020

FDA sets PDUFA goal date of February 28, 2021 Potentially…

CORMEDIX INC. REPORTS SECOND QUARTER AND SIX MONTH 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Written by Sam Nelson on August 10, 2020

Conference Call Scheduled for Today at 4:30 p.m. Eastern Time…

CorMedix Inc. to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 10

Written by Sam Nelson on August 4, 2020

Berkeley Heights, NJ – August 3, 2020 – CorMedix Inc. (NYSE…